학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 4건 | 목록 1~10
Academic Journal
Pinkerton JW; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Preite S; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Piras A; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Zervas D; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Markou T; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Freeman MS; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Hofving T; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Ivarsson E; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Bonvini SJ; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Brailsford W; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Yrlid L; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Belvisi MG; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Birrell MA; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden. mark.birrell@astrazeneca.com.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK. mark.birrell@astrazeneca.com.
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE
Academic Journal
Solomon I; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Amann M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Schlieren, Switzerland. Maria.Amann@Roche.com.; Goubier A; Tusk Therapeutics Ltd., Stevenage Bioscience Catalyst, Stevenage, UK.; Arce Vargas F; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Zervas D; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Qing C; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Henry JY; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Ghorani E; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Akarca AU; Department of Cellular Pathology, University College London Hospital, London, UK.; Marafioti T; Department of Cellular Pathology, University College London Hospital, London, UK.; Śledzińska A; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Werner Sunderland M; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Franz Demane D; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Clancy JR; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Georgiou A; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Salimu J; Tusk Therapeutics Ltd., Stevenage Bioscience Catalyst, Stevenage, UK.; Merchiers P; Tusk Therapeutics Ltd., Stevenage Bioscience Catalyst, Stevenage, UK.; Brown MA; Tusk Therapeutics Ltd., Stevenage Bioscience Catalyst, Stevenage, UK.; Flury R; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Schlieren, Switzerland.; Eckmann J; Roche Innovation Center Munich, Roche Pharmaceutical Research and Development (pRED), Penzberg, Germany.; Murgia C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Schlieren, Switzerland.; Sam J; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Schlieren, Switzerland.; Jacobsen B; Roche Innovation Center Basel, Roche Pharmaceutical Research and Development (pRED), Basel, Switzerland.; Marrer-Berger E; Roche Innovation Center Basel, Roche Pharmaceutical Research and Development (pRED), Basel, Switzerland.; Boetsch C; Roche Innovation Center Basel, Roche Pharmaceutical Research and Development (pRED), Basel, Switzerland.; Belli S; Roche Innovation Center Basel, Roche Pharmaceutical Research and Development (pRED), Basel, Switzerland.; Leibrock L; Roche Innovation Center Basel, Roche Pharmaceutical Research and Development (pRED), Basel, Switzerland.; Benz J; Roche Innovation Center Basel, Roche Pharmaceutical Research and Development (pRED), Basel, Switzerland.; Koll H; Roche Innovation Center Munich, Roche Pharmaceutical Research and Development (pRED), Penzberg, Germany.; Sutmuller R; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Schlieren, Switzerland.; Peggs KS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. k.peggs@ucl.ac.uk.; Quezada SA; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. s.quezada@ucl.ac.uk.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer
Academic Journal
Zervas D; The Goulandris Natural History Museum - Greek Biotope / Wetland Centre, 14th km Thessaloniki-Mihaniona, Thermi, P.O. Box 60394, 57001, Thessaloniki, Greece. dzervas@ekby.gr.; Department of Botany, School of Biology, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece. dzervas@ekby.gr.; Tsiaoussi V; The Goulandris Natural History Museum - Greek Biotope / Wetland Centre, 14th km Thessaloniki-Mihaniona, Thermi, P.O. Box 60394, 57001, Thessaloniki, Greece.; Tsiripidis I; Department of Botany, School of Biology, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece.
Publisher: Springer Country of Publication: Netherlands NLM ID: 8508350 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2959 (Electronic) Linking ISSN: 01676369 NLM ISO Abbreviation: Environ Monit Assess Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Zervas D
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어